Delivery Order SPE2DB20D2014-SPE2DB25FC37Q
- Not listed
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- The Defense Logistics Agency awarded a $5,348.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The award represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $26,828.48 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. As a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for Humulin R 500 unit/mL KwikPen insulin pens (3mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $31,145.42 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,751.10 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on June 5, 2025, with an ultimate completion date of June 6, 2025. This firm fixed price delivery order represents a non-set-aside award under a competitive procurement process. The contract is executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and serves as a child order under the company's broader...
- The Defense Logistics Agency (DLA) awarded a $2,729.66 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by July 24, 2025, with fulfillment occurring at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC37QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of July 7, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, syringes, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for insulin pens reflects the vendor's established role as a primary source for specialty medications and pharmaceutical products serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/3/25 |